ArrowheadPharma's banner
ArrowheadPharma's profile picture

ArrowheadPharma

@ArrowheadPharma • 3,825 subscribers

Arrowhead Pharmaceuticals develops medicines that treat intractable diseases by silencing the genes that cause them.

Shorts

We’ve entered a strategic partnership with Madrigal Pharmaceuticals to advance an RNAi therapeutic for MASH, combining the precision of Arrowhead’s TRiM™ platform with Madrigal’s liver disease expertise. Read the full announcement:

We’ve entered a strategic partnership with Madrigal Pharmaceuticals to advance an RNAi therapeutic for MASH, combining the precision of Arrowhead’s TRiM™ platform with Madrigal’s liver disease expertise. Read the full announcement:

14,517 просмотров

🚨 FDA APPROVED! Arrowhead’s therapy to lower triglycerides in adults with Familial Chylomicronemia Syndrome (FCS) offers new hope for patients & families facing this #RareDisease. A major step forward in RNAi innovation. #FCS #FDAApproval

🚨 FDA APPROVED! Arrowhead’s therapy to lower triglycerides in adults with Familial Chylomicronemia Syndrome (FCS) offers new hope for patients & families facing this #RareDisease. A major step forward in RNAi innovation. #FCS #FDAApproval

18,473 просмотров